AJC Jewel Manufacturers IPO vs Sheel Biotech IPO

Comparison between AJC Jewel Manufacturers IPO and Sheel Biotech IPO.

IPO Details

AJC Jewel Manufacturers IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Sheel Biotech IPO is a SME Bookbuilding proposed to list at NSE SME.

Issue Size and Price

The total issue size of AJC Jewel Manufacturers IPO is up to ₹14.59 Cr whereas the issue size of the Sheel Biotech IPO is up to ₹32.31 Cr. The final issue price of AJC Jewel Manufacturers IPO is ₹95.00 per share and of Sheel Biotech IPO is ₹63.00 per share.

 AJC Jewel Manufacturers IPOSheel Biotech IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)₹90.00 per share₹59.00 per share
Issue Price (Upper)₹95.00 per share₹63.00 per share
Issue Price (Final)₹95.00 per share₹63.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size1200 shares2000 shares
Fresh Issue Size15,36,000 shares51,28,000 shares
Fresh Issue Size (Amount)up to ₹14.59 Crup to ₹32.31 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total15,36,000 shares51,28,000 shares
Issue Size Total (Amount)up to ₹14.59 Crup to ₹32.31 Cr

IPO Timetable

AJC Jewel Manufacturers IPO opens on Jun 23, 2025, while Sheel Biotech IPO opens on Sep 30, 2025. The closing date of AJC Jewel Manufacturers IPO and Sheel Biotech IPO is Jun 26, 2025, and Oct 03, 2025, respectively.

 AJC Jewel Manufacturers IPOSheel Biotech IPO
Anchor Bid DateJun 20, 2025Sep 29, 2025
Issue OpenJun 23, 2025Sep 30, 2025
Issue CloseJun 26, 2025Oct 03, 2025
Basis Of Allotment (Tentative)Jun 27, 2025Oct 06, 2025
Initiation of Refunds (Tentative)Jun 30, 2025Oct 07, 2025
Credit of Share (Tentative)Jun 30, 2025Oct 07, 2025
Listing date (Tentative)Jul 01, 2025Oct 08, 2025
Anchor Lockin End date 1Jul 27, 2025Nov 05, 2025
Anchor Lockin End date 2Sep 25, 2025Jan 04, 2026

Financials & KPIs

AJC Jewel Manufacturers IPO P/E ratio is 12.73, as compared to Sheel Biotech IPO P/E ratio of 8.86.

 AJC Jewel Manufacturers IPOSheel Biotech IPO
Financials

Company Financials (Restated)

Period Ended31 Dec 202431 Mar 202431 Mar 202331 Mar 2022
Assets34.2836.7336.0016.42
Total Income175.53246.84194.25127.40
Profit After Tax1.853.322.041.26
EBITDA3.645.403.942.14
NET Worth13.9012.047.125.08
Reserves and Surplus9.457.604.282.24
Total Borrowing18.4122.4826.236.61
Amount in ₹ Crore

Company Financials (Restated)

Sheel Biotech Ltd.'s revenue increased by 11% and profit after tax (PAT) rose by 2% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 Mar 202531 Mar 202431 Mar 2023
Assets113.28105.9593.89
Total Income102.2792.5580.19
Profit After Tax10.6410.475.08
EBITDA14.9714.458.83
NET Worth83.8572.6963.54
Reserves and Surplus68.9068.5859.40
Total Borrowing17.3623.5419.17
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)76.8596.99
Promoter Shareholding (Post-Issue)56.3371.26
P/E Ratio12.738.86
Market Cap₹56.85 Cr.₹128.22 Cr.
ROE34.6413.59
ROCE17.4716.34
Debt/Equity1.870.21
EPS₹7.46₹7.11
RoNW27.5613.59

Shares Offered

In the AJC Jewel Manufacturers IPO Retail Individual Investors (RII) are offered 5,42,400 shares while in Sheel Biotech IPO retail investors are offered 5,42,400 shares. Qualified Institutional Buyers (QIB) are offered 3,03,600 shares in AJC Jewel Manufacturers IPO and 10,26,000 shares in Sheel Biotech IPO.

 AJC Jewel Manufacturers IPOSheel Biotech IPO
Anchor Investor Reservation4,52,400 shares15,24,000 shares
Market Maker Reservation84,000 shares2,72,000 shares
QIB3,03,600 shares10,26,000 shares
NII2,37,600 shares7,74,000 shares
RII5,42,400 shares18,04,000 shares
Employee0 shares
Others
Total15,36,000 shares51,28,000 shares

Bids Received (Subscription)

AJC Jewel Manufacturers IPO subscribed 2.82x in total, whereas Sheel Biotech IPO subscribed 15.97x.

Compare with others

Compare: